MedPath

KANGDONG SACRED HEART HOSPITAL

🇰🇷South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

18

Active:0
Completed:5

Trial Phases

2 Phases

Phase 4:1
Not Applicable:15

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Not Applicable
15 (93.8%)
Phase 4
1 (6.3%)

Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients

Recruiting
Conditions
Sepsis
First Posted Date
2023-06-22
Last Posted Date
2023-06-22
Lead Sponsor
Kangdong Sacred Heart Hospital
Target Recruit Count
120
Registration Number
NCT05911711
Locations
🇰🇷

KangdonSHH, Seoul, Korea, Republic of

Tailored H. Pylori Eradication Based on Clarithromycin Resistance

Completed
Conditions
Antibiotic Resistant Strain
Helicobacter Pylori Infection
Interventions
First Posted Date
2019-03-21
Last Posted Date
2019-03-21
Lead Sponsor
Kangdong Sacred Heart Hospital
Target Recruit Count
431
Registration Number
NCT03884348

Tailored Therapy for Clarithromycin-Resistant H. Pylori

Not Applicable
Conditions
Helicobacter Pylori Infection
Interventions
Drug: PAM
Drug: PBMT
First Posted Date
2018-02-13
Last Posted Date
2019-03-06
Lead Sponsor
Kangdong Sacred Heart Hospital
Target Recruit Count
660
Registration Number
NCT03431688
Locations
🇰🇷

Kangdong Sacred Heart Hospital, Seoul, Korea, Republic of

Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone

First Posted Date
2015-08-26
Last Posted Date
2018-05-11
Lead Sponsor
Kangdong Sacred Heart Hospital
Target Recruit Count
292
Registration Number
NCT02532634
Locations
🇰🇷

St. Vincent'S Hospital, Suwon, Gyeonggi, Korea, Republic of

🇰🇷

Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of

🇰🇷

Chungnam National University Hospita, Daejeon, Korea, Republic of

and more 7 locations

Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?

Not Applicable
Completed
Conditions
Stomach Ulcer
Interventions
First Posted Date
2010-07-22
Last Posted Date
2015-09-04
Lead Sponsor
Kangdong Sacred Heart Hospital
Target Recruit Count
290
Registration Number
NCT01167101
Locations
🇰🇷

Kangdong Sacred Heart Hospital, Seoul, Korea, Republic of

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.